$sava
Martin Shkreli has published a detailed paper questioning the efficacy of SAVA's simufilam for Alzheimer's, sparking significant discussion and engagement.
About $sava
SAVA is a pharmaceutical company focused on developing treatments for central nervous system disorders.
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Month: [-------] -62%
[--] Months: [---------] +90%
[--] Year: [----------] -59%
1-Year High: [---------] on 2025-09-16
1-Year Low: [---] on 2026-02-15
Engagements by network (24h): X: [-----] Reddit: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
1-Year High: [---] on 2025-11-26
1-Year Low: [--] on 2026-01-04
Mentions by network (24h): X: [--] Reddit: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $sava in the last [--] hours which is up 10% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-11-03
1-Year Low: [--] on 2026-01-06
The most influential creators that mention $sava in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @MartinShkreli | [--] | [-------] | [--] | [-----] |
| @Opal_Chip | [--] | [-----] | [--] | [---] |
| @zachary_hunt7 | [--] | [---] | [--] | [---] |
| @Invest42morrow1 | [--] | [-----] | [--] | [--] |
| @anita37992698 | [--] | [---] | [--] | [--] |
| @REALAdvanced_iP | [--] | [--] | [--] | [--] |
| @mariostario2019 | [--] | [--] | [--] | [--] |
| @t2_j4ngzeji | [--] | [--] | [--] |
Sentiment: 50%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 50%
Daily Average: 76%
[--] Month: 67% +32%
[--] Months: 67% -13%
[--] Year: 67% -22%
1-Year High: 100% on 2025-02-16
1-Year Low: 1% on 2025-09-15
Most Supportive Themes:
- General Stock Mentions: (50%) Posts mentioning a wide variety of stocks, including SAVA, without specific analysis.
- Small-Cap Investment Opportunities: (25%) Posts highlighting potential small-cap stocks with viral setups, mentioning SAVA as an example.
- Investment Discussion Groups: (25%) Posts encouraging participation in groups for stock market decision-making, listing SAVA among other tickers.
Most Critical Themes:
- Simufilam Efficacy Concerns: (100%) A detailed analysis questioning the efficacy of Cassava Sciences' (SAVA) simufilam for Alzheimer's disease.
Top $sava Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"I've written a [--] page paper on why Cassava Sciences' ($SAVA) simufilam does not work for Alzheimer's disease. This is a work-in-progress. But I don't think it doesn't work. It is impossible for it to work. Long thread (1/7)"
X Link @MartinShkreli 2024-11-21T19:33Z 425.4K followers, 4.2M engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing